Yamanaka Kazuaki, Kakuta Yoichi, Nakazawa Shigeaki, Kobayashi Kenichi, Nonomura Norio, Kageyama Susumu
Department of Urology, Shiga University of Medical Science, Otsu 520-2192, Japan.
Department of Urology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
J Clin Med. 2025 May 9;14(10):3307. doi: 10.3390/jcm14103307.
Kidney transplantation significantly improves outcomes in patients with end-stage renal disease; however, postoperative complications remain a substantial concern. This review summarizes the incidence, risk factors, and management strategies for common complications after kidney transplantation. Reported incidence varies widely due to differences in definitions, diagnostic methods, and study designs. Ureteral stenosis occurs in 2.8-18.0% of recipients, vesicoureteral reflux in 0.5-86%, and urinary leakage in 1.1-7.2%. Lymphatic complications, including lymphocele and lymphorrhea, range from 0.6% to 35.2%, with one-third of complications requiring intervention. The incidence of urinary tract infections ranges from 20 to 43%, while asymptomatic bacteriuria is reported in up to 53% of recipients. Surgical site infections have a median incidence of 3.7%, and incisional hernias develop in 2.5-10% of cases, depending on follow-up duration. Vascular complications affect approximately 10% of recipients, with renal artery stenosis and thrombosis being the most prevalent. Neurologic complications, such as femoral nerve palsy and immunosuppression-related neurotoxicity, though less frequent, can impair recovery. Management strategies vary depending on severity, ranging from observation to surgical intervention. Preventive measures-including optimized ureteral stenting protocols, early catheter removal, careful immunosuppression, and appropriate antimicrobial use-play a crucial role in reducing complication risk. Despite advances in transplantation techniques and perioperative care, these complications continue to affect graft survival and patient outcomes. Further research is needed to standardize definitions and establish evidence-based protocols.
肾移植显著改善了终末期肾病患者的预后;然而,术后并发症仍然是一个重大问题。本综述总结了肾移植后常见并发症的发生率、危险因素及管理策略。由于定义、诊断方法和研究设计的差异,报告的发生率差异很大。输尿管狭窄发生在2.8%-18.0%的受者中,膀胱输尿管反流发生率为0.5%-86%,尿漏发生率为1.1%-7.2%。淋巴并发症,包括淋巴囊肿和淋巴漏,发生率在0.6%至35.2%之间,其中三分之一的并发症需要干预。尿路感染的发生率在20%至43%之间,而高达53%的受者报告有无症状菌尿。手术部位感染的中位发生率为3.7%,切口疝的发生率在2.5%-10%之间,具体取决于随访时间。血管并发症影响约10%的受者,其中肾动脉狭窄和血栓形成最为常见。神经并发症,如股神经麻痹和免疫抑制相关神经毒性,虽然发生率较低,但会影响恢复。管理策略因严重程度而异,从观察到手术干预。预防措施,包括优化输尿管支架置入方案、早期拔除导管、谨慎免疫抑制和合理使用抗菌药物,在降低并发症风险方面起着关键作用。尽管移植技术和围手术期护理取得了进展,但这些并发症仍然影响移植物存活和患者预后。需要进一步研究来规范定义并建立基于证据的方案。